These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 6452862)
1. Cardiotropic antimuscarinic action of some curare-like agents. Kharkevich DA; Shorr VA Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):238-50. PubMed ID: 6452862 [TBL] [Abstract][Full Text] [Related]
2. [Effect of curare-like substances on the coronary circulation and myocardial oxygen demand]. Buianov VV Farmakol Toksikol; 1980; 43(6):687-90. PubMed ID: 6450056 [TBL] [Abstract][Full Text] [Related]
3. Cardioselective antimuscarinic action of a dopamine receptor agonist, N,N-dipropyl-2-aminotetralin (TL-68). Sahin I; Ilhan M Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):185-92. PubMed ID: 3446046 [TBL] [Abstract][Full Text] [Related]
4. [Possibility of substance selective action on the m-cholinoreceptors of a specific site]. Kharkevich DA; Skoldinov AP; Samăilov DN; Shorr VA Farmakol Toksikol; 1980; 43(6):645-52. PubMed ID: 7449999 [TBL] [Abstract][Full Text] [Related]
5. [Effect of curare-like agents on the action of acetylcholine]. Shorr VA Farmakol Toksikol; 1972 Jul; 35(4):426-31. PubMed ID: 4261994 [No Abstract] [Full Text] [Related]
6. The antimuscarinic activity of a dopamine receptor agonist (RDS-127) differentiates M2-muscarinic receptors of heart, ileum and trachea in guinea-pig. Sahin I; Ilhan M Arch Int Pharmacodyn Ther; 1988; 296():163-72. PubMed ID: 2907277 [TBL] [Abstract][Full Text] [Related]
7. [The effect of curare-like agents on synaptic transmission in the spinal cord]. Allautdin RN Farmakol Toksikol; 1978; 41(4):397-400. PubMed ID: 208859 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine. Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539 [TBL] [Abstract][Full Text] [Related]
9. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494 [TBL] [Abstract][Full Text] [Related]
10. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression. Vargas HM; Ringdahl B J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503 [TBL] [Abstract][Full Text] [Related]
11. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one. Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004 [TBL] [Abstract][Full Text] [Related]
12. The effect of neuromuscular blocking agents on the acetylcholine receptors of different skeletal muscles. Kharkevich DA; Fisenko VP Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):255-69. PubMed ID: 6269508 [TBL] [Abstract][Full Text] [Related]
13. Urinary bladder-selective action of the new antimuscarinic compound vamicamide. Oyasu H; Yamamoto T; Sato N; Sawada T; Ozaki R; Mukai T; Ozaki T; Nishii M; Sato H; Fujiwara T Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339 [TBL] [Abstract][Full Text] [Related]
14. The affinity of pirenzepine and other antimuscarinic compounds for pre- and postsynaptic muscarine receptors of the isolated rabbit and rat heart. Fuder H Scand J Gastroenterol Suppl; 1982; 72():79-85. PubMed ID: 6958000 [TBL] [Abstract][Full Text] [Related]
15. [The effect of curare-like drugs on M-cholinoreceptors in different locations]. Shorr VA Farmakol Toksikol; 1975; 38(1):38-43. PubMed ID: 123204 [No Abstract] [Full Text] [Related]
16. Pharmacological effects of solifenacin on human isolated urinary bladder. Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763 [TBL] [Abstract][Full Text] [Related]
17. Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder. D'Agostino G; Kilbinger H; Chiari MC; Grana E J Pharmacol Exp Ther; 1986 Nov; 239(2):522-8. PubMed ID: 3772807 [TBL] [Abstract][Full Text] [Related]
18. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Nilvebrant L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Tsai CS; Ochillo RF Arch Int Pharmacodyn Ther; 1991; 310():116-31. PubMed ID: 1772324 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects. Zwagemakers JM; Claassen V Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]